Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1980-07-14
1986-09-02
Rollins, Alton D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544346, 544349, 560 60, A61K 3148, C07D51902
Patent
active
046096574
ABSTRACT:
This invention provides compounds of ##STR1## wherein R.sub.1 is benzyl or benzyl substituted by hydroxy, chlorine, fluorine, amino, amido, (C.sub.2-5) alkanoylamino, (C.sub.1-4) alkyl, (C.sub.1-4) alkylamino, (C.sub.1-4) alkoxy, (C.sub.1-4) alkylamido, di[(C.sub.1-4) alkyl]amino, or di[(C.sub.1-4) alkyl]amino,
R.sub.2, R.sub.4 and R.sub.5 are each (C.sub.1-4) alkyl, and
R.sub.3 is (C.sub.2-4) alkyl
are prolactin secretion promoters.
REFERENCES:
patent: 3422110 (1969-01-01), Stadler et al.
patent: 3586683 (1971-06-01), Stadler et al.
patent: 3846433 (1974-11-01), Stadler et al.
patent: 4145549 (1979-03-01), Stadler
Stadler Paul
Troxler Franz
Honor Robert S.
McGovern Thomas O.
Rollins Alton D.
Sandoz Ltd.
Sharkin Gerald D.
LandOfFree
Ergot peptide alkaloid derivatives, processes for their preparat does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ergot peptide alkaloid derivatives, processes for their preparat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ergot peptide alkaloid derivatives, processes for their preparat will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1097774